BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37323166)

  • 1. Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study.
    Xu SJ; Chen RQ; Tu JH; You CX; Chen C; Zhang ZF; Divisi D; Migliore M; Bongiolatti S; Durand M; Sato M; Kuroda H; Yang CF; Yu SB; Chen SC
    Transl Lung Cancer Res; 2023 May; 12(5):1078-1092. PubMed ID: 37323166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer.
    Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M
    J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT.
    Park S; Lee SM; Choe J; Choi S; Do KH; Seo JB
    Radiology; 2023 May; 307(3):e222422. PubMed ID: 36943079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Analysis of the Impact of Micropapillary Component on Different Recurrence Patterns of Pathological Stage IA3 Lung Adenocarcinoma: A Multicenter, Retrospective Study.
    Xu SJ; Chen C; Tu JH; You CX; Chen RQ; Zhang ZF; Chen SC
    Ann Surg Oncol; 2024 Feb; 31(2):872-882. PubMed ID: 37962740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ground glass opacity resection extent assessment trial
    Li H; Wang Y; Chen Y; Zhong C; Fang W
    Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study.
    Yu S; You C; Yan R; Chen H; Chen C; Xu S; Gonzalez M; Chen R; Kang M; Chen S
    Transl Lung Cancer Res; 2022 Nov; 11(11):2275-2288. PubMed ID: 36519020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.
    Xu SJ; Tu JH; Chen H; Yan RH; Chen RQ; Chen C; You CX; Zhang ZF; Yu SB; Chen SC
    Ann Surg Oncol; 2023 Sep; 30(9):5843-5853. PubMed ID: 37219654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes.
    Li M; Wang J; Bao X; Wang F; Zhou F; Song N; Wan Z; Li W; Zhang L
    AJR Am J Roentgenol; 2024 May; ():. PubMed ID: 38809121
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct clinicopathologic factors and prognosis based on the presence of ground-glass opacity components in patients with resected stage I non-small cell lung cancer.
    Wang C; Wu Y; Li J; Ren P; Gou Y; Shao J; Zhou Y; Xiao X; Tuersun P; Liu D; Zhang L; Li W
    Ann Transl Med; 2020 Sep; 8(18):1133. PubMed ID: 33240982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity.
    Li R; Li Z; Yang Z; Qiu B; Tan F; Xue Q; Gao S; He J
    Transl Lung Cancer Res; 2024 Feb; 13(2):256-268. PubMed ID: 38496684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
    Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma.
    Zhai W; Liang D; Duan F; Wong W; Yan Q; Gong L; Lai R; Dai S; Long H; Wang J
    Front Cell Dev Biol; 2021; 9():769881. PubMed ID: 34957101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance.
    Ma Z; Han H; Cao H; Wang S; Li Y; Zhang Y; Chen H
    Transl Lung Cancer Res; 2023 Nov; 12(11):2181-2192. PubMed ID: 38090517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
    Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
    Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
    Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
    Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
    J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Prognostic Factors of Ground Glass Opacity and Pure-Solid Lesion in Pathological Stage I Invasive Lung Adenocarcinoma.
    Zhai WY; Wong WS; Duan FF; Liang DC; Gong L; Dai SQ; Wang JY
    World J Oncol; 2022 Oct; 13(5):259-271. PubMed ID: 36406190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.